Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Lori Woods, CEO of Isoray, Inc.
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Isoray Discusses CEO Transition, Vision for the Company and Value Catalysts Moving Forward
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Blue Jay Mining: Advancing High-Grade Ilmenite Assets in Greenland
00:10:00
Embracing Philotimo: The Power of Values and Community Leadership | Michael G. Psaros, Co-Founder, KPS Capital Partners.
00:10:00
Andy Wallgren: Sales Special Projects Manager at Fisher Wavy
00:10:00
Accor CEO Sébastien Bazin on Strategic Acquisitions, Brand Expansions, and Future Vision | Sébastien Bazin, CEO , Accor SA.
00:10:00
Insights into Oak Hill Advisors' Strategic Approach in Distressed and Private Credit Markets |Glenn August , CEO, Oak Hill Advisors.
00:10:00
President of the Management Board of XTPL, Filip Granek in an interview for Biznes24 TV 23 03 2022 | Filip Granek, CEO, XTPL SAXTP:WSE
00:10:00
Revolutionizing Eyewear: How Graber Built Germany's Largest Selection of Glasses Online | Dirk Graber , CEO, Mister Spex SE.
00:10:00
Fortune Minerals Secures $16.2M Funding for Nico Project Expansion
00:10:00
Disrupting Traditional Funding: The Rise of Equity Crowdfunding | Nir Vulkan - Associate Professor of Business Economics, Oxford Saïd Business School
00:10:00
Why Florida Announces Election Results Quickly|Lawer Ben
00:10:00
Matt Riehle: Championing Diversity at Morgan Lewis | MATTHEW N. RIEHLE - ASSOCIATE of Morgan, Lewis & Bockius LLP
00:10:00
Adapting to Higher Energy Prices: Antoine Lesne of State Street Global Advisors Discusses Inflation, ECB Insights, and Investor Positioning in European and ETF Markets